Gastric Outlet Obstruction

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
1 program
EUS-guided gastroenterostomyN/A1 trial
Active Trials
NCT05605327UnknownEst. Oct 2024
GT Biopharma
GT BiopharmaSAN FRANCISCO, CA
1 program
Magnet SystemN/A1 trial
Active Trials
NCT07317076RecruitingEst. Nov 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
GT BiopharmaMagnet System
Verona PharmaEUS-guided gastroenterostomy

Clinical Trials (2)

GT Metabolic Magnet System in Adults With Gastrointestinal Disorders

Start: Dec 2025Est. completion: Nov 2026
N/ARecruiting
NCT05605327Verona PharmaEUS-guided gastroenterostomy

EUS-guided Versus Laparoscopic Gastrojejunostomy for Malignant Gastric Outlet Obstruction

Start: Nov 2022Est. completion: Oct 2024
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space